April 2012

Description: The Scripps Research Institute

Description: At the Forefront

Description: Divider

Focus On:

Description: Charles CochraneScripps Research Professor Emeritus Charles Cochrane

FDA approves drug for premature infants

Twenty years after an eminent Scripps Research Institute scientist made a major research breakthrough, the FDA has approved a potentially life-saving drug that helps premature infants breathe.

The new drug helps prevent and treat respiratory distress syndrome using a synthetic lung coating created by Charles Cochrane, a Scripps Research immunologist.

"I couldn't believe my ears when I heard about the approval," said Cochrane, who was among the famed group of researchers to come to Scripps Research in 1961. "This is going to save a lot of lives and a lot of money."

Read More »

Description: Divider

Milestones in Medical Science:

Description: Philip LoGrassoPhilip LoGrasso, professor in the Department of Molecular Therapeutics

Moving closer to developing a potential Parkinson's drug

Scripps Research scientists aren't content with accolades for their lab work – they are adamant about getting their discoveries to patients as quickly as possible.

That's why Scripps Florida has granted a license to a prominent South Florida biopharmaceutical firm for the commercial development of a newly discovered compound, which could lead to a potentially groundbreaking treatment for Parkinson's disease.

"This is one of the best opportunities we have for the development of an effective neuroprotective treatment for Parkinson's patients," said Scripps Research Professor Phillip LoGrasso.

Read More »

Description: Divider

Other News:

Description: Associate Professor Andrew ButlerA rendition of the bioinformatics analysis superimposed between two neurons.

Researchers find new target for pain relief

Scripps Research investigators recently made a big discovery: a potential new target for treating pain caused by nerve damage.

Neuropathic pain affects millions of people worldwide, but it is difficult to treat and is in many ways still a mystery to scientists. That mystery led a team of scientists from Scripps Research to try a new approach called metabolomics, which involves looking at the biochemical intermediates and end-products of body processes like respiration and the creation and breakdown of molecules.

What they found could be big news for a field of medicine that still lacks effective drugs.

Read more and watch the video »

Facts & Figures

Parkinson's disease affects approximately 1 million Americans and current drugs only slow the progression of the disease.

A model that works

The Scripps Research Institute is a unique combination – more academically rigorous than many universities, but proud to work with industry to bring life-saving discoveries to patients. Your support provides seed money to make these high-impact discoveries possible. Please donate today.

Description: Donate Now

Description: Connect to us on Facebook

Description: https://www.kintera.com/AccountTempFiles/account106289/images/2011atfwhiteleft.jpg

Description: https://www.kintera.com/AccountTempFiles/account106289/images/2011atfwhitemiddle.jpg

Description: https://www.kintera.com/AccountTempFiles/account106289/images/2011atfwhiteleft.jpg

Description: Tell A Friend

Plan now to reap benefits for next year's taxes

With your 2011 taxes just filed, now is the time to start thinking about 2012. Scripps Research has many planned giving options which offer exceptional yields and numerous tax advantages during this time of uncertainty. Visit our Planned Giving page or reach out to our qualified staff to learn more.

Description: Charity Navagator

California: 10550 North Torrey Pines Road TPC2 - La Jolla CA 92037 - 858.784.2037
Florida: 130 Scripps Way 4B2 - Jupiter FL 33458 - 561.228.2013
email: philanthropy@scripps.edu - www.supportcures.org

Description: http://omt.kintera.org/omt/5658193632.gif